Latest filing published 14 Oct 2020 for Aimmune Therapeutics, Inc., €1.2M.
Filing timeline
BuySaleInsider track record
Daniel C. Adelman MD: trading record in brief
All filings by Daniel C. Adelman MD on record concern Aimmune Therapeutics, Inc. The record holds 25 filings, for trades running from 25 September 2017 to 13 October 2020.
Sales make up the whole of the open-market record (9 sales, €3.0M). Outside the open market, there are 6 share grants and 8 option exercises. So far in 2020, the count stands at no purchases and 1 sale.
The latest filing, published on 14 October 2020, reports a transaction of €1.2M in Aimmune Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel C. Adelman MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 41,464 shares@ US$34.5037.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028171:0
- 22,343 shares@ US$34.5020.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028171:1
- 34,932 shares@ US$11.4510.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-027460:0
- 840 shares@ US$34.250.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-025342:0
- 2,420 shares0Common Stock, $0.0001 par valueSEC:0000899243-20-012850:0
- 1,872 shares@ US$23.811.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-007093:0
- 8,750 shares0Common Stock, $0.0001 par valueSEC:0000899243-20-006851:0
- 20,000 shares@ US$19.638.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-000395:0
- 20,000 shares@ US$35.0015.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-000395:1
- 20,000 shares@ US$11.455.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-19-028948:0
- 20,000 shares@ US$30.0413.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-19-028948:1
- 11,875 shares0Common Stock, $0.0001 par valueSEC:0000899243-19-004864:0
- 9,375 shares0Common Stock, $0.0001 par valueSEC:0000899243-18-006564:0
- 26,784 shares@ US$11.454.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-001089:0
- 26,784 shares@ US$40.0013.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-001089:1
- 9,933 shares@ US$11.451.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-001089:2
- 9,933 shares@ US$40.005.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-001089:3
- 3,283 shares@ US$11.450.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029733:0
- 3,283 shares@ US$40.001.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029733:1
- 10,000 shares@ US$11.451.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-024683:0
- 5,530 shares@ US$33.252.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-024683:1
- 1,470 shares@ US$34.270.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-024683:2
- 3,000 shares@ US$35.461.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-024683:3
- 10,000 shares@ US$11.451.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-022646:0
- 10,000 shares@ US$25.003.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-022646:1
25 of 25 declarations
